As of Friday close, Oak Street Health Inc.’s (NYSE:OSH) stock was up $2.79, moving up 18.34 percent to $18.00. The average number of shares traded per day over the past five days has been 2,786,900 shares. 3 times new highs have been achieved over the past 5 days, with a $0.65 gain in that time frame. In the last twenty days, the average volume was 2,133,860, while in the previous 50 days, it was 2,363,572.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .
Since last month, OSH stock retreated -30.37%. Shares of the company fell to $13.29 on 05/12/22, the lowest level in the past month. A 52-week high of $65.22 was reached on 01/03/22 after having rallying from a 52-week low of $13.29. Since the beginning of this year, OSH’s stock price has dropped by -45.68% or -$15.14, and marked a new high 1 time. However, the stock has declined by -72.40% since its 52-week high.
Oak Street Health Inc. (OSH) last reported insider trading activity 11 days ago on May 03. PRICE GEOFFREY M, the Chief Innovation Officer of the company, disposed of 60,000 shares for $18.91 on May 03. It resulted in a $1,134,310 divestment by the insider. PRICE GEOFFREY M sold 60,000 shares at an average price of $24.91 on Apr 19. The insider now owns 2,073,270 shares following the transaction. On Apr 05, Chief Innovation Officer PRICE GEOFFREY M sold 60,000 shares at $26.56 apiece. The transaction was valued at $1,593,523.
In the three months ended September 29, Oak Street Health Inc.’s quick ratio stood at 2.10, while its current ratio was 2.10, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 17.54. On the profitability front, the trailing twelve-month gross margin is 1.90% percent. In the year ended September 29, operating margins totaled -22.00%. Based on annual data, OSH earned $29.9 million in gross profit and brought in $1.43 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -43.30%. Return on equity (ROE) for the past 12 months was -206.60%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. OSH’s revenue rose 42.25% to $394.1 million during the quarter, while net income inched up to $513.8 million. While analysts expected Oak Street Health Inc. to report -$0.42 quarterly earnings, the actual figure was -$0.49 per share, beating the consensus estimate by -16.70%. During the quarter, the company generated -$79.9 million in EBITDA. The liabilities of Oak Street Health Inc. were 1.91 billion at the end of its most recent quarter ended September 29, and its total debt was $1.07 billion. The value of shareholders’ equity is $241.07 million.
This quick technical analysis looks at Oak Street Health Inc.’s (OSH) price momentum. With a historical volatility rate of 140.92%, the RSI 9-day stood at 47.96% on 13 May.
With respect to its five-day moving average, the current Oak Street Health Inc. price is up by +3.75% percent or $0.65. At present, OSH shares trade -30.50% below its 20-day simple moving average and -46.04% percent below its 100-day simple moving average. However, the stock is currently trading approximately -16.16% below its SMA50 and -71.37% below its SMA200.
Stochastic coefficient K was 28.38% and Stochastic coefficient D was 14.68%, while ATR was 2.06. Given the Stochastic reading of 60.77% for the 14-day period, the RSI (14) reading has been calculated as 44.54%. As of today, the MACD Oscillator reading stands at -1.23, while the 14-day reading stands at -1.89.
UBS launched its rating on Oak Street Health Inc. (NYSE: OSH) to a Neutral in a note to investors on April 20, 2022. Oak Street Health Inc. (OSH) has been rated Overweight by analysts. According to 0 brokerage firms, OSH is a sell, and 5 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 3 analysts rate Oak Street Health Inc. stock as buy, with 11 recommending it as overweight.
With a median target price of $31.50, the current consensus forecast for the stock is $19.00 – $43.00. Based on these forecasts, analysts predict Oak Street Health Inc. (OSH) will achieve an average price target of $30.63.